Opioid-Induced Constipation Market - Global Outlook and Forecast 2022-2028

Opioid-Induced Constipation Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Opioid-Induced Constipation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid-Induced Constipation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid-Induced Constipation Overall Market Size
2.1 Global Opioid-Induced Constipation Market Size: 2021 VS 2028
2.2 Global Opioid-Induced Constipation Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Opioid-Induced Constipation Sales: 2017-2028
3 Company Landscape
3.1 Top Opioid-Induced Constipation Players in Global Market
3.2 Top Global Opioid-Induced Constipation Companies Ranked by Revenue
3.3 Global Opioid-Induced Constipation Revenue by Companies
3.4 Global Opioid-Induced Constipation Sales by Companies
3.5 Global Opioid-Induced Constipation Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Opioid-Induced Constipation Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Opioid-Induced Constipation Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid-Induced Constipation Players in Global Market
3.8.1 List of Global Tier 1 Opioid-Induced Constipation Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid-Induced Constipation Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid-Induced Constipation Market Size Markets, 2021 & 2028
4.1.2 Methylnaltrexone Bromide
4.1.3 Lubiprostone
4.1.4 Naloxegol
4.1.5 Others
4.2 By Type - Global Opioid-Induced Constipation Revenue & Forecasts
4.2.1 By Type - Global Opioid-Induced Constipation Revenue, 2017-2022
4.2.2 By Type - Global Opioid-Induced Constipation Revenue, 2023-2028
4.2.3 By Type - Global Opioid-Induced Constipation Revenue Market Share, 2017-2028
4.3 By Type - Global Opioid-Induced Constipation Sales & Forecasts
4.3.1 By Type - Global Opioid-Induced Constipation Sales, 2017-2022
4.3.2 By Type - Global Opioid-Induced Constipation Sales, 2023-2028
4.3.3 By Type - Global Opioid-Induced Constipation Sales Market Share, 2017-2028
4.4 By Type - Global Opioid-Induced Constipation Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Opioid-Induced Constipation Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Opioid-Induced Constipation Revenue & Forecasts
5.2.1 By Application - Global Opioid-Induced Constipation Revenue, 2017-2022
5.2.2 By Application - Global Opioid-Induced Constipation Revenue, 2023-2028
5.2.3 By Application - Global Opioid-Induced Constipation Revenue Market Share, 2017-2028
5.3 By Application - Global Opioid-Induced Constipation Sales & Forecasts
5.3.1 By Application - Global Opioid-Induced Constipation Sales, 2017-2022
5.3.2 By Application - Global Opioid-Induced Constipation Sales, 2023-2028
5.3.3 By Application - Global Opioid-Induced Constipation Sales Market Share, 2017-2028
5.4 By Application - Global Opioid-Induced Constipation Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Opioid-Induced Constipation Market Size, 2021 & 2028
6.2 By Region - Global Opioid-Induced Constipation Revenue & Forecasts
6.2.1 By Region - Global Opioid-Induced Constipation Revenue, 2017-2022
6.2.2 By Region - Global Opioid-Induced Constipation Revenue, 2023-2028
6.2.3 By Region - Global Opioid-Induced Constipation Revenue Market Share, 2017-2028
6.3 By Region - Global Opioid-Induced Constipation Sales & Forecasts
6.3.1 By Region - Global Opioid-Induced Constipation Sales, 2017-2022
6.3.2 By Region - Global Opioid-Induced Constipation Sales, 2023-2028
6.3.3 By Region - Global Opioid-Induced Constipation Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Opioid-Induced Constipation Revenue, 2017-2028
6.4.2 By Country - North America Opioid-Induced Constipation Sales, 2017-2028
6.4.3 US Opioid-Induced Constipation Market Size, 2017-2028
6.4.4 Canada Opioid-Induced Constipation Market Size, 2017-2028
6.4.5 Mexico Opioid-Induced Constipation Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Opioid-Induced Constipation Revenue, 2017-2028
6.5.2 By Country - Europe Opioid-Induced Constipation Sales, 2017-2028
6.5.3 Germany Opioid-Induced Constipation Market Size, 2017-2028
6.5.4 France Opioid-Induced Constipation Market Size, 2017-2028
6.5.5 U.K. Opioid-Induced Constipation Market Size, 2017-2028
6.5.6 Italy Opioid-Induced Constipation Market Size, 2017-2028
6.5.7 Russia Opioid-Induced Constipation Market Size, 2017-2028
6.5.8 Nordic Countries Opioid-Induced Constipation Market Size, 2017-2028
6.5.9 Benelux Opioid-Induced Constipation Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Opioid-Induced Constipation Revenue, 2017-2028
6.6.2 By Region - Asia Opioid-Induced Constipation Sales, 2017-2028
6.6.3 China Opioid-Induced Constipation Market Size, 2017-2028
6.6.4 Japan Opioid-Induced Constipation Market Size, 2017-2028
6.6.5 South Korea Opioid-Induced Constipation Market Size, 2017-2028
6.6.6 Southeast Asia Opioid-Induced Constipation Market Size, 2017-2028
6.6.7 India Opioid-Induced Constipation Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Opioid-Induced Constipation Revenue, 2017-2028
6.7.2 By Country - South America Opioid-Induced Constipation Sales, 2017-2028
6.7.3 Brazil Opioid-Induced Constipation Market Size, 2017-2028
6.7.4 Argentina Opioid-Induced Constipation Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid-Induced Constipation Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Opioid-Induced Constipation Sales, 2017-2028
6.8.3 Turkey Opioid-Induced Constipation Market Size, 2017-2028
6.8.4 Israel Opioid-Induced Constipation Market Size, 2017-2028
6.8.5 Saudi Arabia Opioid-Induced Constipation Market Size, 2017-2028
6.8.6 UAE Opioid-Induced Constipation Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Takeda Pharmaceuticals
7.1.1 Takeda Pharmaceuticals Corporate Summary
7.1.2 Takeda Pharmaceuticals Business Overview
7.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Major Product Offerings
7.1.4 Takeda Pharmaceuticals Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Pharmaceuticals Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Opioid-Induced Constipation Major Product Offerings
7.2.4 Bayer Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Opioid-Induced Constipation Major Product Offerings
7.3.4 Sanofi Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Mallinckrodt
7.4.1 Mallinckrodt Corporate Summary
7.4.2 Mallinckrodt Business Overview
7.4.3 Mallinckrodt Opioid-Induced Constipation Major Product Offerings
7.4.4 Mallinckrodt Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.4.5 Mallinckrodt Key News
7.5 Salix (Bausch Health)
7.5.1 Salix (Bausch Health) Corporate Summary
7.5.2 Salix (Bausch Health) Business Overview
7.5.3 Salix (Bausch Health) Opioid-Induced Constipation Major Product Offerings
7.5.4 Salix (Bausch Health) Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.5.5 Salix (Bausch Health) Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Opioid-Induced Constipation Major Product Offerings
7.6.4 AstraZeneca Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Progenics Pharmaceuticals
7.7.1 Progenics Pharmaceuticals Corporate Summary
7.7.2 Progenics Pharmaceuticals Business Overview
7.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Major Product Offerings
7.7.4 Progenics Pharmaceuticals Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.7.5 Progenics Pharmaceuticals Key News
7.8 Purdue Pharm
7.8.1 Purdue Pharm Corporate Summary
7.8.2 Purdue Pharm Business Overview
7.8.3 Purdue Pharm Opioid-Induced Constipation Major Product Offerings
7.8.4 Purdue Pharm Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.8.5 Purdue Pharm Key News
7.9 Nektar Therapeutics
7.9.1 Nektar Therapeutics Corporate Summary
7.9.2 Nektar Therapeutics Business Overview
7.9.3 Nektar Therapeutics Opioid-Induced Constipation Major Product Offerings
7.9.4 Nektar Therapeutics Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.9.5 Nektar Therapeutics Key News
7.10 Daiichi Sankyo
7.10.1 Daiichi Sankyo Corporate Summary
7.10.2 Daiichi Sankyo Business Overview
7.10.3 Daiichi Sankyo Opioid-Induced Constipation Major Product Offerings
7.10.4 Daiichi Sankyo Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.10.5 Daiichi Sankyo Key News
7.11 Prestige
7.11.1 Prestige Corporate Summary
7.11.2 Prestige Opioid-Induced Constipation Business Overview
7.11.3 Prestige Opioid-Induced Constipation Major Product Offerings
7.11.4 Prestige Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.11.5 Prestige Key News
7.12 GSK
7.12.1 GSK Corporate Summary
7.12.2 GSK Opioid-Induced Constipation Business Overview
7.12.3 GSK Opioid-Induced Constipation Major Product Offerings
7.12.4 GSK Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.12.5 GSK Key News
7.13 Shionogi
7.13.1 Shionogi Corporate Summary
7.13.2 Shionogi Opioid-Induced Constipation Business Overview
7.13.3 Shionogi Opioid-Induced Constipation Major Product Offerings
7.13.4 Shionogi Opioid-Induced Constipation Sales and Revenue in Global (2017-2022)
7.13.5 Shionogi Key News
8 Global Opioid-Induced Constipation Production Capacity, Analysis
8.1 Global Opioid-Induced Constipation Production Capacity, 2017-2028
8.2 Opioid-Induced Constipation Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid-Induced Constipation Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioid-Induced Constipation Supply Chain Analysis
10.1 Opioid-Induced Constipation Industry Value Chain
10.2 Opioid-Induced Constipation Upstream Market
10.3 Opioid-Induced Constipation Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid-Induced Constipation Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Opioid-Induced Constipation in Global Market
Table 2. Top Opioid-Induced Constipation Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Opioid-Induced Constipation Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Opioid-Induced Constipation Revenue Share by Companies, 2017-2022
Table 5. Global Opioid-Induced Constipation Sales by Companies, (K Units), 2017-2022
Table 6. Global Opioid-Induced Constipation Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Opioid-Induced Constipation Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Opioid-Induced Constipation Product Type
Table 9. List of Global Tier 1 Opioid-Induced Constipation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid-Induced Constipation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Opioid-Induced Constipation Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Opioid-Induced Constipation Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Opioid-Induced Constipation Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Opioid-Induced Constipation Sales (K Units), 2017-2022
Table 15. By Type - Global Opioid-Induced Constipation Sales (K Units), 2023-2028
Table 16. By Application - Global Opioid-Induced Constipation Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Opioid-Induced Constipation Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Opioid-Induced Constipation Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Opioid-Induced Constipation Sales (K Units), 2017-2022
Table 20. By Application - Global Opioid-Induced Constipation Sales (K Units), 2023-2028
Table 21. By Region - Global Opioid-Induced Constipation Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Opioid-Induced Constipation Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Opioid-Induced Constipation Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Opioid-Induced Constipation Sales (K Units), 2017-2022
Table 25. By Region - Global Opioid-Induced Constipation Sales (K Units), 2023-2028
Table 26. By Country - North America Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Opioid-Induced Constipation Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Opioid-Induced Constipation Sales, (K Units), 2017-2022
Table 29. By Country - North America Opioid-Induced Constipation Sales, (K Units), 2023-2028
Table 30. By Country - Europe Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Opioid-Induced Constipation Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Opioid-Induced Constipation Sales, (K Units), 2017-2022
Table 33. By Country - Europe Opioid-Induced Constipation Sales, (K Units), 2023-2028
Table 34. By Region - Asia Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Opioid-Induced Constipation Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Opioid-Induced Constipation Sales, (K Units), 2017-2022
Table 37. By Region - Asia Opioid-Induced Constipation Sales, (K Units), 2023-2028
Table 38. By Country - South America Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Opioid-Induced Constipation Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Opioid-Induced Constipation Sales, (K Units), 2017-2022
Table 41. By Country - South America Opioid-Induced Constipation Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Opioid-Induced Constipation Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Opioid-Induced Constipation Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Opioid-Induced Constipation Sales, (K Units), 2023-2028
Table 46. Takeda Pharmaceuticals Corporate Summary
Table 47. Takeda Pharmaceuticals Opioid-Induced Constipation Product Offerings
Table 48. Takeda Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Bayer Corporate Summary
Table 50. Bayer Opioid-Induced Constipation Product Offerings
Table 51. Bayer Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Opioid-Induced Constipation Product Offerings
Table 54. Sanofi Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Mallinckrodt Corporate Summary
Table 56. Mallinckrodt Opioid-Induced Constipation Product Offerings
Table 57. Mallinckrodt Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Salix (Bausch Health) Corporate Summary
Table 59. Salix (Bausch Health) Opioid-Induced Constipation Product Offerings
Table 60. Salix (Bausch Health) Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Opioid-Induced Constipation Product Offerings
Table 63. AstraZeneca Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Progenics Pharmaceuticals Corporate Summary
Table 65. Progenics Pharmaceuticals Opioid-Induced Constipation Product Offerings
Table 66. Progenics Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Purdue Pharm Corporate Summary
Table 68. Purdue Pharm Opioid-Induced Constipation Product Offerings
Table 69. Purdue Pharm Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Nektar Therapeutics Corporate Summary
Table 71. Nektar Therapeutics Opioid-Induced Constipation Product Offerings
Table 72. Nektar Therapeutics Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Daiichi Sankyo Corporate Summary
Table 74. Daiichi Sankyo Opioid-Induced Constipation Product Offerings
Table 75. Daiichi Sankyo Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Prestige Corporate Summary
Table 77. Prestige Opioid-Induced Constipation Product Offerings
Table 78. Prestige Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. GSK Corporate Summary
Table 80. GSK Opioid-Induced Constipation Product Offerings
Table 81. GSK Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Shionogi Corporate Summary
Table 83. Shionogi Opioid-Induced Constipation Product Offerings
Table 84. Shionogi Opioid-Induced Constipation Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Opioid-Induced Constipation Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Opioid-Induced Constipation Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Opioid-Induced Constipation Production by Region, 2017-2022 (K Units)
Table 88. Global Opioid-Induced Constipation Production by Region, 2023-2028 (K Units)
Table 89. Opioid-Induced Constipation Market Opportunities & Trends in Global Market
Table 90. Opioid-Induced Constipation Market Drivers in Global Market
Table 91. Opioid-Induced Constipation Market Restraints in Global Market
Table 92. Opioid-Induced Constipation Raw Materials
Table 93. Opioid-Induced Constipation Raw Materials Suppliers in Global Market
Table 94. Typical Opioid-Induced Constipation Downstream
Table 95. Opioid-Induced Constipation Downstream Clients in Global Market
Table 96. Opioid-Induced Constipation Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Opioid-Induced Constipation Segment by Type
Figure 2. Opioid-Induced Constipation Segment by Application
Figure 3. Global Opioid-Induced Constipation Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Opioid-Induced Constipation Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid-Induced Constipation Revenue, 2017-2028 (US$, Mn)
Figure 7. Opioid-Induced Constipation Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Opioid-Induced Constipation Revenue in 2021
Figure 9. By Type - Global Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 10. By Type - Global Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 11. By Type - Global Opioid-Induced Constipation Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 13. By Application - Global Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 14. By Application - Global Opioid-Induced Constipation Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 16. By Region - Global Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 17. By Country - North America Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 18. By Country - North America Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 19. US Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 24. Germany Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 25. France Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 33. China Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 37. India Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 39. By Country - South America Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 40. Brazil Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Opioid-Induced Constipation Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Opioid-Induced Constipation Sales Market Share, 2017-2028
Figure 44. Turkey Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Opioid-Induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 48. Global Opioid-Induced Constipation Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Opioid-Induced Constipation by Region, 2020 VS 2027
Figure 50. Opioid-Induced Constipation Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs